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Phytochemical studies are seeking new alternatives to prevent or treat cancer, including
different types of leukemias. Campomanesia adamantium, commonly known as guavira
or guabiroba, exhibits pharmacological properties including antioxidant, antimicrobial,
and antiproliferative activities. Considering the anticancer potential of this plant species,
the aim of this study was to evaluate the antileukemic activity and the chemical
composition of aqueous extracts from the leaves (AECL) and roots (AECR) of C.
adamantium and their possible mechanisms of action. The extracts were analyzed
by LC-DAD-MS, and their constituents were identified based on the UV, MS, and
MS/MS data. The AECL and AECR showed different chemical compositions, which
were identified as main compounds glycosylated flavonols from AECL and ellagic acid
and their derivatives from AECR. The cytotoxicity promoted by these extracts were
evaluated using human peripheral blood mononuclear cells and Jurkat leukemic cell
line. The cell death profile was evaluated using annexin-V-FITC and propidium iodide
labeling. Changes in the mitochondrial membrane potential, the activity of caspases,
and intracellular calcium levels were assessed. The cell cycle profile was evaluated using
propidium iodide. Both extracts caused concentration-dependent cytotoxicity only in
Jurkat cells via late apoptosis. This activity was associated with loss of the mitochondrial
membrane potential, activation of caspases-9 and -3, changes in intracellular calcium
levels, and cell cycle arrest in S-phase. Therefore, the antileukemic activity of the AECL
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and AECR is mediated by mitochondrial dysfunction and intracellular messengers, which
activate the intrinsic apoptotic pathway. Hence, aqueous extracts of the leaves and roots
of C. adamantium show therapeutic potential for use in the prevention and treatment of
diseases associated the proliferation of tumor cell.
Keywords: natural products, medicinal plant, LC-MS, cancer, bioprospecting
INTRODUCTION
Leukemias are cancers that affect white blood cells (Yan et al.,
2014), which are responsible for activation of the immune system.
Leukemia can be classified as lymphocytic or myeloid according
to the cellular origin and as either acute or chronic according to
the progression of the disease.
To control or inhibit the proliferation of altered
leukemic cells in patients, various treatment strategies
can be combined, including chemical treatment,
radiological treatment, and stem cell transplantation. In
this context, the natural products have been suggesting
novel alternatives to prevent or treat cancer, including
different types of leukemias (Asmaa et al., 2014; Kinghorn,
2015).
Campomanesia adamantium (Cambess.) O. Berg (Myrtaceae),
commonly known as guavira or guabiroba, is a small tree
endemic to Brazil that produces edible fruits that are widely
used in the production of liqueurs, juices, and jellies (Coutinho
et al., 2008; Pavan et al., 2009). The leaves and fruits
of C. adamantium are used in the traditional medicine
as anti-inflammatory, antidiarrheal, and are effective against
urinary infections diseases (Vieira et al., 2011), and the
roots are used in the treatment of diabetes (Coutinho et al.,
2008).
Studies on the chemical composition from C. adamantium
have indicated the presence of phenolic compounds, such as
chalcones (Pavan et al., 2009; Pascoal et al., 2011, 2014),
flavanones and flavonols (Coutinho et al., 2010), as well as gallic
acid, and ellagic acid (Espindola et al., 2016).
Besides, previous studies have reported antimicrobial (Pavan
et al., 2009; Cardoso et al., 2010), antiproliferative (Pascoal
et al., 2014), anti-inflammatory, antidepressant, antihyperalgesic,
and antidiarrheal activities of the fruits (Lescano et al.,
2016; Souza et al., 2017). The roots exhibits antioxidant and
antihyperlipidemic effects (Espindola et al., 2016). In adition, the
essential oil of the leaves exhibits antimicrobial and antioxidant
properties (Coutinho et al., 2009), and leaf extracts show anti-
inflammatory, antinociceptive (Ferreira et al., 2013), antioxidant
(Coutinho et al., 2010; Pascoal et al., 2011), and antiproliferative
activity against prostate cancer cells by decreased the expression
of NFkB1 and induction of apoptosis (Pascoal et al., 2014).
However, to the best of our knowledge, no previous studies
have described the activities of this plant species in leukemic
cells.
Considering the anticancer potential of C. adamantium, the
aim of this study was to evaluate the antileukemic activity of
aqueous extracts of its leaves and roots, their mechanisms of
action as well as its chemical composition.
MATERIALS AND METHODS
Botanical Specimens and Preparation of
Extracts
C. adamantiumO. Berg leaves and roots were collected following
the identification of the plant and authorization of the SISBIO
(Sistema de Autorização e Informação em Biodiversidade, permit
number 54470).
Leaves and roots of C. adamantium O. Berg were collected in
Dourados, in the state ofMato Grosso do Sul, Brazil (coordinates:
22◦ 02′ 47.9 S′ and 055◦ 08′ 14.3′ W). The samples were cleaned,
dried in a convection oven at 45◦C, and ground using a Croton
knife mill. An exsiccated sample was deposited in the Herbarium
of the Federal University of Grande Dourados, Mato Grosso do
Sul, Brazil, with registration number 4108.
Extracts were prepared from the powdered material using an
accelerated solvent extractor (ASE R©-150, Dionex), as described
by Espindola et al. (2016). The samples were placed in a cell
of 100 mL and extracted with distilled water at temperature of
125◦C through two 5 min static cycles, with an 80% flush volume
and a 60 s purge. The extracts were lyophilized to obtain the
dry extract. Thus, the aqueous extracts of Campomanesia leaves
(AECL) and roots (AECR) were obtained with a yield of 13 and
6%, respectively.
Identification of Constituents by Liquid
Chromatography Coupled to Array Diode
Detector and Mass Spectrometry
(LC-DAD-MS)
The analyses were performed at a Shimadzu Prominence UFLC
coupled to a diode array detector (DAD) and amass spectrometer
(MicrOTOF-Q III, Bruker Daltonics) with an electrospray ion
source. Kinetex C18 (2.6 µm, 150 × 2.1 mm, Phenomenex)
chromatographic column was used. The AECL and AECR
extracts were prepared at concentration 1mg/mL and the volume
of 1 µL was injected on the chromatography. The flow rate
and oven temperature were 0.3mL/min and 50◦C, respectively.
Formic acid 0.1% (v/v) in both water (solvent A) and acetonitrile
(solvent B) were used as mobile phase, applying the following
gradient elution profile: 0–8min at 3% B, 8–30min at 3–25%
B, 30–60min at 25–80% B, and 60–63min at 80% B. The MS
analyses were carried out both ion modes (positive and negative),
applying 2.5 kV of capillary voltage. Nitrogen was used as
nebulizer gas (4 Bar), dry (9 L/min) and collisional gas.
Cell Line and Culture Conditions
Human peripheral blood mononuclear cells from healthy donors
were collected after informed patient consent. Separation of
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mononuclear cells was performed by gradient centrifugation
methods using Ficoll Histopaque-1077 (1.077 g/cm3) (Sigma–
Aldrich, Germany) follow the manufacturer’s instructions at 400
g for 30 min. The use of human samples was approved by the
local Ethical Committee of the University Center of the Grande
Dourados under protocol number 123/12.
The Jurkat (human acute T lymphocytic leukemia) cell line
was cultured in suspension in RPMI 1640 medium (Cultilab,
Brazil) supplemented with 10% fetal calf serum (FBS, Cultilab,
Brazil), 100 U/mL penicillin, and 100 µg/mL streptomycin in a
humidified atmosphere at 37◦C under 5% CO2.
Cytotoxic Activity
Peripheral blood mononuclear cells and Jurkat cells were seeded
(105 cells/mL) in 96-well microplates containing medium with
vinblastine (positive control), EACL or EACR at different
concentrations. After incubation for 24 h, the treatments were
removed and 100 µL of 10% Alamar Blue solution was added.
After 5 h, the fluorescence was read at 530 nm (Ex) and 590 nm
(Em) in a microplate reader FlexStation 3 (Molecular Devices,
USA). Each experiment was performed in triplicate.
Cell Death Profile
The cell death profile was evaluated according to the methods
described by Paredes-Gamero et al. (2012), with minor
modifications. Jurkat cells were seeded in 96-well plates (105
cells/mL) and cultured in medium containing 10% FBS for 24
h with IC50 of AECL (40 µg/mL) or AECR (80 µg/mL) and
the double of these concentrations. After this period, the cells
were washed with PBS and resuspended in annexin labeling
buffer (0.01 M Hepes, pH 7.4, 0.14 M NaCl, and 2.5 mM
CaCl2). The suspensions were labeled with annexin-FITC and
propidium iodide (PI) (Becton Dickinson, USA) according to the
manufacturer’s instructions, and the cells were incubated at room
temperature for 15 min. Finally, 10,000 events were collected per
sample through analysis in a Accuri C6 flow cytometer (Becton
Dickinson, USA) using FlowJo v10.2 LCC software (Oregon,
USA).
Measurement of the Mitochondrial
Membrane potential (19mit)
Mitochondrial depolarization was evaluated through the
incorporation of JC-1 (5,5′,6,6′–tetrachloro—1,1′,3,3′—
tetraethylbenzimidazolylcarbocyanine iodide; Molecular
Probes, Eugene, OR, USA) according to the method described
by Moraes et al. (2013). JC-1 is cationic dye that shows potential-
dependent accumulation in mitochondria via fluorescence
emission. Cells that stained red were classified as exhibiting a
high mitochondrial membrane potential, while those that stained
green were classified as exhibiting a low membrane potential. For
these assays, cells were seeded in 24-well plates (105 cells/mL),
where they were cultured in medium containing 10% FBS
and treated with IC50 of the AECL or AECR, for 24 h. After
treatment, the cells were centrifuged and incubated with JC-1
(1 µg/mL) at room temperature for 15 min. Fluorescence was
analyzed in a FACScalibur Flow Cytometer (Becton Dickinson,
USA) using CellQuest software (10,000 events were collected per
sample).
Western Blot Analysis
Antibodies against actin, Bcl-2 and Bax were obtained from
Santa Cruz Biotecnology (Santa Cruz, CA, USA), whereas the
monoclonals anti-cleaved caspase-9 and anti-cleaved caspase-8
antibodies were from Cell Signaling Technologies (Beverly, MA,
USA). Horseradish peroxidase-conjugated secondary antibodies
against rabbit (goat anti-rabbit), mouse (goat anti-mouse), and
goat (donkey anti-goat) were from Millipore (Temecula, CA,
USA).
After treatment with IC50 of the AECL or AECR, cells
were harvested in a lysis buffer (50 mM Tris-HCl, pH 7.4),
1% Tween-20, 0.25% sodium deoxycholate, 150 mM NaCl,
1mM EGTA, 1mM o-Vanadate, 1mM NaF, and 1X protease
inhibitor cocktail (Thermo Fisher Scientific, Rockford, IL, USA)
on ice for 2 h, and after clarification, protein concentration was
determined using the Pierce BCA Protein Assay kit (Thermo
Fisher Scientific). Equal volume of 2X SDS gel loading buffer
was added and samples were boiled for 5 min. Cellular
extracts were subjected to SDS-PAGE (10%) and transferred
to nitrocellulose membranes. Blots were probed overnight at
4◦C with appropriate primary antibodies at 1:1,000 dilutions.
After washing in TBS/0.05% Tween-20, membranes were
incubated with anti-goat, anti-rabbit, or anti-mouse horseradish
peroxidase-conjugated secondary antibody at 1:3,000 dilutions
for 1 h. Blots were imaged using Pierce SuperSignal West Pico
Chemiluminescent Substrate (Thermo Fisher Scientific) on a
LAS-3000 imaging system.
Caspase-3 Activity
The activation of caspase-3 was evaluated via flow cytometry
according to the method described by Moraes et al. (2013),
with minor modifications. Cells were seeded in 24-well plates
(105 cells/mL), where they were cultured in medium containing
10% FBS and treated with IC50 of the AECL or AECR, for
24 h. After treatment, the cells were centrifuged, washed,
and fixed in 2% paraformaldehyde in PBS for 30 min.
The cells were then washed with glicin (0.1 M) in PBS,
permeabilized with 0.01% saponin for 30 min, and blocked
in PBS containing 1% BSA for 30 min at room temperature.
Subsequently, the cells were incubated with an anti-active-
caspase-3 monoclonal antibody conjugated with FITC (BD-
Pharmingen, San Diego, CA, USA) in the dark at room
temperature for 40 min. After incubation, fluorescence was
analyzed in a FACScalibur Flow Cytometer (Becton Dickinson,
USA) using CellQuest software (10,000 events were collected per
sample).
Pan-Caspase Inhibitor and Intracellular
Calcium
The importance of caspases and calcium for AECL or AECR
cytotoxicity was evaluated according to the method described by
Bechara et al. (2014), with minor modifications. Briefly, Jurkat
cells that had been pretreated for 1 h with 10 µM of the Z-VAD-
FMK (general caspases inhibitor) or 10 µM of the BAPTA-AM
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FIGURE 1 | Chromatographic profile at wavelength 230–350 nm of the aqueous extracts of roots (AECR) and leaves (AECL) from C. adamantium.
(a calcium chelator) before AECL or AECR incubation for 24 h,
both with IC50 values, were subjected to trypan blue exclusion
assays. To assess cell viability, control and treated cells were
resuspended in equal volumes of medium and trypan blue (0.05%
solution) and were counted using a hemocytometer chamber.
Ca2+ Measurement
Cytosolic Ca2+ concentration [Ca2+]cyt was determined by
incubating 105 Jurkat cells/well in black 96-well microplates
with the Fluo-4 Direct Calcium Assay reagent according to the
manufacturer’s instructions (Life, USA). After 1 h of indicator
incorporation at 37◦C, cells were stimulated with IC50 of
the AECL or AECR and the fluorescence was quantified in
a FlexStation 3 microplate reader (Molecular Devices, USA).
Ionomycin 0.1 µM, was used as positive control to obtain the
maximal fluorescence. The Fluo-4 was excited at 490 nm, and the
emission was detected at 525 nm (Leon et al., 2011). The records
of fluorescence intensity as a function of time correspond to the
mean of experiment performed in quadruplicate.
Cell Cycle Phases
To determine the cell cycle distribution, Jurkat cells were seeded
(105 cells/mL) and cultured in medium containing 10% FBS and
were treated with IC50 of the AECL or AECR, for 24 h. After
this period, the cells were washed, fixed and permeabilized as
described previously. Then, the cells were treated with 4 µg/mL
RNase type I for 1 h at 37◦C and resuspended in PBS. The cells
were subsequently stained with 5 µg/mL PI and analyzed (12,000
events collected per sample) in an Accuri C6 flow cytometer
(Becton Dickinson, USA). The DNA content was evaluated using
an FL2A detector on a linear scale. The dead cells were excluded
to cell cycle analysis. The analyses of the cell percentage in
the G1/S/G2 phases were performed using FlowJo v10.2 LCC
software.
Intracellular Protein Labeling
To investigate the mechanisms of extracts-induced cell cycle
arrest, Jurkat cells were seeded in 24-well plates (105 cells/mL),
where they were cultured in medium containing 10% FBS
and treated with IC50 of the AECL or AECR, for 24 h. After
this period, were fixed with 2% paraformaldehyde for 10
min, washed with BD Perm/Wash buffer and permeabilized
with BD Perm Buffer III for 30 min. Then, the cells were
labeled with 5 µL Ki-67-FITC antibody (Becton Dickinson,
USA). To label phosphorylated retinoblastoma protein (p-
Rb) anti-p-Rb (Ser780) (Cell Signaling, USA) antibody
was used. After permeabilization intracellular protein was
incubated for 1 h. Then, anti-rabbit IgG secondary antibody
conjugated with Alexa Fluor 488 (Life, USA) were used for
40 min. Protein analyses were performed by quantification
of the fluorescence geometric mean (Gm). The cells were
analyzed in an Accuri C6 flow cytometer (Becton Dickinson,
USA) using FlowJo v10.2 LCC software (Torquato et al.,
2017).
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FIGURE 2 | Chemical structures some identified compounds and aglycones from C. adamantium.
Statistical Analyses
The data are shown as the mean ± standard error of the mean
(SEM) and were analyzed for statistically significant differences
between groups. Student’s t-test was employed for comparisons
between two groups, and one-way analysis of variance (ANOVA)
followed by Dunnett’s test was employed for comparisons of
more than two groups using Prism 5 GraphPad Software. The
results were considered significant when P < 0.05.
RESULTS
Identification of Constituents from the
Extracts
The constituents from AECR and AECL were identified based on
the UV, high resolution MS and MS/MS data (Figure 1, Table 1)
and the comparison to the published data (Fabre et al., 2001;
March et al., 2006; Ferreres et al., 2013; Guaratini et al., 2014;
Zhang et al., 2016). The main compounds identified from AECR
were di-hexoside/quinic acid (1), ellagic acid O-pentoside (27),
ellagic acid (30), O-methyl ellagic acid O-hexoside (31), ellagic
acidO-deoxyhexoside (33), andO-methyl ellagic acid sulfate (39)
(Table 1). In addition, other constituents were identified such as
gallic acid (3), ellagic acid O-hexoside (20), O-methyl ellagic acid
O-deoxyhexoside (43), and O-dimethyl ellagic acid sulfate (44)
(Figure 2).
While fromAECL, forty-two compounds have been identified.
The main constituents identified were di-hexoside/quinic
acid (1), myricetin O-pentoside (23, 26, 29), myricetin O-
deoxyhexoside (32), quercetin O-pentoside (38), and myricetin
O-(O-galloyl)-pentoside (40).
The peaks 5–9, 11–12, 14, 18–19, 21–22, and 28 (Table 1)
presented a similar UV (λmax ≈ 280 nm), which are compatible
to flavan-3-ols (Markham, 1982). The typical fragmentation for
condensed tannins was observed for these chromatographic
peaks, including the heterocyclic ring fission, reto-Diels-Alder
(RDA) and quinone methide reactions (Gu et al., 2003; Guaratini
et al., 2014; Nocchi et al., 2017). The condensed tannins esterified
with gallic acid were confirmed by fragment ion at m/z 169
[M-H-flavan-3-ol units]
−
, such as for 14, 18, 22, and 28. The
monomers were confirmed by co-injection of authentic standard
as gallocatechin (5), epigallocatechin (6), catechin (7), and
epicatechin (12)(Figure 2).
The compounds 19, 23–26, 29, 32, 34–38, 40–42, and 45
exhibited UV spectra relative to flavonols (Markham, 1982). The
losses of 162, 146, 132, and 152 u confirmed the presence of
hexoside, deoxyhexoside, pentoside, and gallic acid, respectively.
The identification of aglycones was based on product ions yielded
from C-ring fissions, as widely described in the literature (Fabre
et al., 2001; March et al., 2006), and they corroborated to the
aglycones quercetin, kaempferol, and myricetin. In addition, the
compounds 47 and 48 showed intense ions at m/z 269 [M-H]−
and 271 [M+H]+, compatible to molecular formula C16H14O4
and UV spectra characteristic of flavanone. The determination
of the methyl position in A-ring was established from elution
time described for 5,7-dihydroxy-6-methylflavanone and 5,7-
dihydroxy-8-methylflavanone, which were isolated from C.
adamantium (Coutinho et al., 2010).
The compounds 20, 27, 30, 31, 33, 39, 43, and 44 showed
UV spectra compatible to ellagic acid (Ferreres et al., 2013).
From m/z 303.0128 [M+H]+ (C14H7O8
+, error 4.5 ppm)
of compound 30 were yielded the product ions at m/z 275,
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FIGURE 3 | Viability of peripheral blood mononuclear cells (PBMC) and Jurkat
cells treated with different concentrations of the vinblastine (A), AECL (B), and
AECR (C). *p < 0.05, **p < 0.01, and ***p < 0.001 compared with the control
group.
257, and 247, which are relative to subsequent eliminations
of CO (28 u) and water molecules and they were compatible
to ellagic acid (confirmed by co-injection of the standard)
(Ferreres et al., 2013; Zhang et al., 2016). The losses of 15
and 80 u confirmed the presence of methoxyl (31, 39, 44)
and sulfate substituents (39, 44) and they were identified
as O-methyl ellagic acid sulfate and O-dimethyl ellagic acid
sulfate, respectively. Similar sulfate ellagic acid derivatives have
been described from Lagerstroemia speciosa (Lythraceae) and
Euphorbia sororia (Euphorbiaceae) (Bai et al., 2008; Zhang et al.,
2008). The derivatives of ellagic acid were only detected from C.
adamantium roots.
Cytotoxic Activity
Peripheral blood mononuclear cells and Jurkat cells were
treated with vinblastine, AECL or AECR to assess cell
viability. Vinblastine promoted cell death in Peripheral blood
mononuclear cells (IC50 = 25.9 µg/mL) and Jurkat cells
(IC50 = 9.5 µg/mL) (Figure 3A). The AECL did not
change the viability of Peripheral blood mononuclear cells
at the evaluated concentrations, however, promoted death in
Jurkat cell (IC50 = 40 µg/mL) (Figure 3B). AECR showed
low cytotoxicity against Peripheral blood mononuclear cells
only at the highest concentration evaluated (160 µg/mL),
but demonstrated concentration-dependent cytotoxicity against
Jurkat cells (IC50 = 80 µg/mL) (Figure 3C).
Cell Death Profile
Both extracts resulted in double staining (annexin V+/PI+),
indicating late apoptosis. This type of death was observed in 76.1
± 3.2% of the cells treated with 80 µg/mL AECL (Figure 4A)
and in 65.1 ± 1.4% of the cells treated with 160 µg/mL AECR
(Figure 4B).
Mitochondrial Membrane Potential (19mit)
19mit was decreased in cells treated with AECL and AECR
compared with untreated cells, as demonstrated by decreased
red fluorescence and increased green fluorescence after a 24-h
incubation. The rates of mitochondrial depolarization in cells
treated with AECL and AECR were 85.4 ± 8.2 and 84.5 ± 2.0%,
respectively (Figures 5A,B).
Expression of Caspases, Blc-2, and Bax
In order to evaluate the role of the extrinsic and intrinsic
pathways of apoptosis in cell death, protein expression of
cleaved-caspases-8 and -9, Bcl-2, and Bax were investigated
by western blot. As demonstrated in Figure 6A, the extrinsic
pathway did not influence the mechanism of action of these
extracts as evidenced by the absence of the characteristic
fragments of cleaved caspase-8 (Asp391). In contrast, there was
an increase in the cleaved form of caspase-9 (Asp330) in cellular
extracts treated with both AECL and AECR, suggesting a role
for the intrinsic pathway in mediating apoptosis. Moreover,
this was followed by a slight increase in the expression
of Bax, whereas no alteration was seen in Bcl-2 expression
(Figure 6B).
A monoclonal anti-cleaved caspase-3 antibody was used
to evaluate caspase-3 activation in cells incubated with
AECL and AECR, and the cells were analyzed via flow
cytometry. Both extracts resulted in the cleavage of pro-
caspase 3, as indicated by a shift in fluorescence to the right
(Figures 7A,B). Caspase-3 activation was 5.0-fold higher in
cells treated with AECL (Figure 7A) and 2.5-fold higher in
cells treated with AECR compared with the untreated control
(Figure 7B).
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FIGURE 4 | Cell death profile after treatment with AECL (A) and AECR (B). Data obtained via flow cytometry of cells stained with annexin V-FITC/PI; Anx–/PI–: viable
cells; Anx+/PI–: apoptotic cells; Anx–/PI+: necrotic cells, and Anx+/PI+: cells in late apoptosis. *p < 0.05, **p < 0.01, and ***p < 0.001 compared with the control
group.
Pan-Caspase Inhibitor and Intracellular
Calcium Levels
Jurkat cells were pre-incubated with Z-VAD-FMK, a general
caspase inhibitor, to assess whether caspases were involved in
the cytotoxicity induced by the tested extracts. We observed
that AECL-induced cytotoxicity decreased after treatment with
the inhibitor (Figure 8A), indicating that caspases are actively
involved in the cytotoxicity of this extract. However, pre-
incubation with Z-VAD-FMK resulted in no difference in the
viability of cells treated with AECR (Figure 8B).
Additionally, Jurkat cells were pre-incubated with BAPTA-
AM, an intracellular Ca2+ chelator, to investigate the role of Ca2+
in the cytotoxicity induced by the extracts. Our results showed
that AECL- and AECR-induced cytotoxicity was decreased after
treatment with BAPTA-AM (Figures 8A,B), demonstrating the
importance of calcium in the cytotoxic activity of the extracts in
this cell line.
To corroborate the involvement of cytoplasmatic Ca2+ in
cell death AECL and AECR- induced we performed a temporal
evaluation of Ca2+ concentration. Both compounds were able
to promoted increase of Ca2+ concentration in Jurkat cells
(Figures 9A,B).
Cell Cycle Distribution
The effect of the extracts on the cell cycle distribution is shown
in Figure 10A. The numbers of Jurkat cells in G1 phase were
decreased by 16.6 ± 1.3 and 8.0 ± 0.5% after 24 h of treatment
with AECL and AECR, respectively, compared with untreated
cells. The number of cells in S phase after treatment with AECL
and AECR increased to 23.86 and 25.23%, respectively, compared
with untreated cells 17.66% (Figures 10A,B).
The arrest of cell cycle was confirmed by the quantification of
Ki-67 protein, a protein only expressed during the cell division
cycle, and by quantification of p-Rb, a protein that prevent the
progression of cell cycle when is not phosphorylated. Ki-67 was
not altered by AECL, whereas AECR promoted a reduction of
27.3 ± 0.1% (Figure 11A). Furthermore, the cell cycle arrest was
also confirmed by the reduction of p-RB levels (AECL 27.9 ±
3.7%; AECR 58.5± 2.5%) (Figure 11B).
DISCUSSION
The fruits of C. adamantium are widely consumed freshly, and
to produce liqueurs, juice and sweets (Pavan et al., 2009). Several
chemical and biological studies have been performed from the
fruits (Pavan et al., 2009; Cardoso et al., 2010; Pascoal et al., 2014;
Lescano et al., 2016; Souza et al., 2017). However, the studies from
leaves and roots are still underexplored, representing a huge and
important issue to comprehend their biological properties in this
study and others.
The AECR and AECL showed huge differences from chemical
constituents. AECR basically showed ellagic acid and its
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FIGURE 5 | Mitochondrial membrane potential of Jurkat cells treated with AECL (A) and AECR (B). ***p < 0.001 compared with the control group.
FIGURE 6 | Western blot analysis. Jurkat Cells were treated with vehicle (control) or with the extracts for 24 h and were harvested for western blot analysis. The
expression of (A) cleaved caspase-8 (Asp391) and (B) cleaved caspase-9 (Asp330) (37 kDa), Bax, Bcl-2 was determined by western blot. Equal loading was
confirmed by reprobing blots for actin. One representative immunoblot of two independent experiments was presented.
derivatives, (methoxylated, glycosylated, and sulfated), as well
as organic acids in its composition. Differently, the AECL
revealed mainly glycosylated flavonols, flavanones, flavan-3-ols,
and condensed tannins. The main compounds identified from
AECL were the flavonols myricetin O-pentoside (23, 26, 29),
myricetin O-deoxyhexoside (32), quercetin O-pentoside (38),
and myricetin O-(O-galloyl)-pentoside (40).
Brazilian biodiversity is rich in active compounds with high
potential for development of new anticancer agents (Campos
et al., 2016). Among the 174 anticancer drugs that have been
commercially available in recent decades, ∼10% are of natural
origin, and 25% are derived from natural products (Newman
and Cragg, 2016). These percentages underscore the need to
the search for new sources of bioactive compounds for cancer
therapy. In this study, the analysis of the cytotoxic potential of
extracts of C. adamantium leaves and roots in leukemic Jurkat
cells revealed that both extracts induced cell death; however, the
leaf extract was more effective than the root extract.
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FIGURE 7 | Caspase-3 activation in Jurkat cells treated with AECL (A) and AECR (B). ***p < 0.001 compared with the control group.
These results suggest that most of the biologically active
compounds found in this plant species are likely concentrated
in the leaves, which showed chemical composition extremely
different of roots and explain the differences at biological
properties. Pascoal et al. (2014) showed that the compound
cardamonin was predominantly found in extracts of the leaves
and fruits of C. adamantium, and the higher antiproliferative
activity associated with the leaves was correlated with the higher
concentration of this phenolic compound.
In the present study, analysis of the cell death profile induced
by the C. adamantium extracts demonstrated a predominance of
late apoptotic death against Jurkat cells. This type of cell death,
also known as post-apoptotic or secondary necrotic death (Patel
et al., 2006), does not involve phagocytosis and is characterized
by the activation of mechanisms similar to those of necrosis
(Krysko et al., 2008). Late apoptotic death involves molecular
and biochemical events typical of both apoptosis and necrosis.
It is initiated by nuclear fragmentation, intensive chromatin
condensation, and the release of activated caspase-3, which
are typical events in apoptosis, leading to other activities that
are characteristic of necrotic cell death, including cytoplasmic
swelling, permeabilization of the cell membrane, and loss of
membrane integrity (Silva, 2010).
Our results regarding the mechanism of action associated
with the cytotoxicity of Jurkat cells indicated that both extracts
promoted depolarization of the mitochondrial membrane. Dorn
(2013) observed that apoptosis-mediated cell death is ATP
dependent and requires energy to maintain mitochondrial
respiration; thus, the opening of pores in the outer mitochondrial
membrane is controlled by pro-apoptotic Bcl-2 family proteins,
which bind to Bax and/or Bak molecules, in turn, contributing
to the induction of apoptosis. In cells undergoing necrosis-
induced death, the loss of 19mit is ATP independent, and
the opening of pores in the mitochondrial membrane is not
controlled by other proteins, leading to osmotic swelling of the
mitochondrial matrix and, consequently, expansion and rupture
of the outer mitochondrial membrane (Proskuryakov et al., 2003;
Dorn, 2013).
The cell death observed in the present study was likely
mediated by the intrinsic apoptotic pathway, which involves
the loss of 19mit. The opening of pores in the mitochondrial
membrane releases pro-apoptotic molecules, such as cytochrome
C, from the intermembrane space of mitochondria to the
cytosol, resulting in the formation of a complex known as the
apoptosome, together with apoptotic protease activating factor-
1 (APAF-1), procaspase 9, and ATP (Kim et al., 2003; Aguiar
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FIGURE 8 | Effect of a pan-caspase inhibitor (Z-VAD-FMK) and an intracellular
calcium chelator (BAPTA-AM) on cell death mediated by AECL (A) and AECR
(B). *p < 0.05 compared with the control group. #p < 0.05 compared with the
AECL or AECR group.
et al., 2012). In this process, procaspase 9 is cleaved and becomes
caspase-9, which, in turn, cleaves procaspase-3 into caspase-3
(Proskuryakov et al., 2003; Li and Yuan, 2008). The last enzyme
is partially or fully responsible for the proteolytic cleavage of
critical proteins such as poly (ADP-ribose) polymerase (a DNA
repair enzyme; Cohen, 1997) and the final stages of apoptosis
(Sakulnarmrat et al., 2013).
To evaluate whether the extracts of the leaves and roots
of C. adamantium promote the activation of caspases, protein
expression of cleaved-caspases-8 and -9 were investigated by
western blot and the monoclonal antibody anti-cleaved caspase-3
and a pan-caspase inhibitor were used. The activation of caspase-
9 and -3 confirmed the involvement of the intrinsic pathway of
apoposis in the cell death induced by both extracts. However, only
the death of cells treated with AECLwas reversed after incubation
with the general caspase inhibitor.
Caspases are a family of aspartate-specific cysteine proteases
present in the cell cytoplasm in an inactive form (known as
procaspases) and are activated either by autoproteolysis induced
by interaction with adapter proteins (death effector domains or
caspase recruitment domains) or via cleavage by other proteases
(Krysko et al., 2008). In addition to these mechanisms of action,
calcium ions are involved in the death of Jurkat cells. Calcium
is essential for the regulation of cell death in apoptosis by
interacting with Bcl-2 family proteins such as Bax and Bid, which
induce apoptosis via the mitochondrial pathway (Orrenius et al.,
2015) and necrosis via intracellular Ca2+ overload, leading to loss
of mitochondrial permeability (Lemasters et al., 1999; Festjens
et al., 2006).
Calcium may activate Bax, which induces permeabilization
of the mitochondrial membrane and release of mitochondrial
pro-apoptotic factors, culminating in the activation of cell death
effector caspases such as caspase-3 (Nutt et al., 2002), which is
also activated by AECL and AECR.
The cytotoxic activity of C. adamantium extracts is associated
with their chemical composition. Anticancer activities have been
described for gallic and ellagic acid, both identified in AECL
and AECR. The gallic acid triggers death in various cell lines
via the intrinsic and extrinsic apoptotic pathways (Faried et al.,
2007; Wang et al., 2014). Ellagic acid induces apoptosis in acute
myeloid leukemia cells and is involved in the activation of
caspase-3 (Hagiwara et al., 2010). In addition, this compound also
induces changes on nuclear deoxyribonucleoside triphosphate
(Saiko et al., 2015), and inhibits the proliferation of tumor cells
by activating the TGF-β/Smad3 signaling pathway as well as
proteins involved in cell proliferation and differentiation and by
inducing cell cycle arrest (Zhang et al., 2014).
Cell cycle arrest is considered an effective strategy for
eliminating cancer cells (Cho et al., 2011). The cell cycle
is a complex process that involves interplay between several
regulatory molecules, including cyclins and cyclin-dependent
kinases (CDKs) (Zhu et al., 2015). The irregular metabolism of
tumor cells is associated with failure of this process, resulting in
uncontrolled cell proliferation (Zhang et al., 2015). The extracts
evaluated in this study decreased the number of cells in G0/G1
phase and increased the number in S phase of the cell cycle.
Additionally, AECR reduces Ki-67 and p-Rb protein levels,
involved in the mechanisms of cell cycle proliferation and arrest,
respectively, while AECL decreases only p-Rb levels. Ki-67 is a
nuclear protein detected during the cell cycle and it is a marker of
cell proliferation (Torquato et al., 2017). The retinoblastoma (Rb)
protein, when phosphorylated by the cyclin-CDK complexes,
induces the expression of transcriptional factors such as E2F,
promoting the advancement of the cycle (Hamilton and Infante,
2016). Therefore, compounds that reduces proliferation and/or
leads to death of cancer cells through different mechanisms are
of paramount importance, particularly when they are effective in
leukemic cell lines that are resistant to certain types of cell death.
From AECL, several glycosylated flavonols of quercetin
and myricetin aglycones were detected, which could also be
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FIGURE 9 | Increases in [Ca2+]cyt induced by AECL (A) and AECR (B) in Jurkat cells. Cell were loaded with Fluo-4 Direct Calcium Assay Kit. The detection of
fluorescence was performed in a FlexStation 3 microplate reader. Ionomycin was used as positive control to obtain the maximal fluorescence.
FIGURE 10 | Cell cycle distribution after treatment with AECL (A) and AECR (B) for 24 h. *p < 0.05 compared with the control group.
related to the activity, since the inhibition on the growth of
human promyelocytic leukemia cells were reported for quercetin
3-O-β-D-glucopyranoside (Kim et al., 2000). For the non-
glycosylated flavonols quercetin, kaempferol and myricetin, the
proteasome-inhibition, and apoptosis-inducing activities have
been reported in human tumor cells (Chen et al., 2005), as well as
the structure-activity relationships of flavonoids for cytotoxicity
on human leukemia cells (Plochmann et al., 2007). From this
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FIGURE 11 | Quantification of Ki-67 (A) and p-Rb (B) in Jurkat cells treated with AECL and AECR. **p < 0.01, and ***p < 0.001 compared with the control group.
study, the structural features for higher activity was determined,
such as the carbon-carbon double bond on C ring, the carbonyl
on C-4, the hydroxylation on B ring and other. Some of these
features can be found in the flavonoids from C. adamantium
extracts, but there are not wide studies from its glycosylated
derivatives and also for the ellagic acid derivatives, mainly for
leukemic cells.
Other studies also demonstrate the antileukemic potential of
plant extracts, including mechanisms similar to those presented
by extracts of C. adamantium, such as the reduction of
mitochondrial membrane potential (Casagrande et al., 2014;
Santos et al., 2016), increase Bax protein expression, activation
of caspases-9 and -3, and cell cycle arrest (Asmaa et al., 2014; Fan
et al., 2016). Furthermore, the AECL showed similar citotoxicity
to the crude extract of Pereskia sacharosa leaves (Asmaa et al.,
2014), and higher than those obtained by extracts from leaves
of P. sacharosa (Asmaa et al., 2014), Jacaranda decurrens
(Casagrande et al., 2014), and Hancornia speciosa (Santos et al.,
2016).
In conclusion, this study revealed for the first time that
aqueous extracts of the leaves and roots of C. adamantium
exert antileukemic activity via late apoptosis by decreasing the
mitochondrial membrane potential, increasing the activation of
caspase-9 and 3, and intracellular calcium levels. Hence, these
extracts show therapeutic potential for use in the prevention and
treatment of diseases associated the proliferation of tumor cell.
Besides, the extensive chemical identification of the constituents
from AECL and AECR were determined, demonstrating huge
chemical differences between the extracts that can explain the
biological properties.
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